MS Hug

An “MS hug” is an unpredictable and often frightening symptom experienced by many people with multiple sclerosis. The MS hug typically feels like a very strong and sometimes painful squeezing […]

Read News Article

FDA Approves Briumvi for the Treatment of Relapsing Forms of MS

TG Therapeutics has announced that the United States Food and Drug Administration (FDA) approved Briumvi™ (ublituximab-xiiy) for the treatment of relapsing forms of multiple sclerosis (MS) in adults – including clinically isolated syndrome, relapsing-remitting MS, and active secondary-progressive MS. This medication is a monoclonal antibody that targets CD20, a protein found on the surface of B cells, and induces B-cell depletion within 24 hours. B cells are white blood cells shown to play a role in MS.

Read News Article